Species specificity of lupus-like anticoagulants
- 1 October 1986
- journal article
- research article
- Published by Springer Nature in Annals of Hematology
- Vol. 53 (4) , 287-292
- https://doi.org/10.1007/bf00320886
Abstract
Mixing studies using activated partial thromboplastin time (APTT) technique were performed on 14 patients with lupus-like anticoagulants (LLACs) using human, equine, bovine, porcine and canine plasma. Eleven patients significantly prolonged the APTT of normal human plasma (patient/control ratio=>1.15) but no patient inhibited bovine plasma. However, with one exception, equine APTT ratios were concordant with human ratios. Seven of fourteen patients also inhibited porcine plasma but in each case porcine APTT ratios were lower than their human or equine counterparts. None of five patients tested inhibited canine plasma. Collectively, these results suggest heterogeneity among LLACs at least with regard to species specificity.This publication has 13 references indexed in Scilit:
- The Lupus Inhibitor: A Study of Its HeterogeneityThrombosis and Haemostasis, 1981
- In vitro correction of anticoagulant activity and specific clotting factor assays in SLEThrombosis Research, 1980
- The Varied Sensitivity of Partial Thromboplastin and Prothrombin Time Reagents in the Demonstration of the Lupus‐Like AnticoagulantScandinavian Journal of Haematology, 1979
- A Sensitive Test Demonstrating Lupus Anticoagulant and its Behavioural PatternsBritish Journal of Haematology, 1978
- A clinical study of the lupus anticoagulantBlood, 1976
- CLINICAL-STUDY OF LUPUS ANTICOAGULANT1976
- Naturally Occurring Species Specific Inhibitor of Human Prothrombin in Lupus Erythematosus.Experimental Biology and Medicine, 1964